Eran Orr: The Need For Better ADHD Screening

October 19, 2020
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Screenings for ADHD have not improved in several years.

While treatment for attention deficit/hyperactivity disorder (ADHD) have improved over time, diagnostics generally have not.

For the last several decades, screenings and diagnostics for ADHD has been done through questionnaires for the patient, as well as for teachers and parents of patients.

There remains a need to improve that.

In an interview with HCPLive®, Evan Orr, Founder and CEO of XRHealth, said he is hopeful that new technology could be used to better screen patients for ADHD.

XRHealth recently unveiled a new ADHD virtual reality platform with the goal of improving well-known ADHD cognitive functioning, including attention, impulsivity, and higher and more complex thinking functions such as initiating, organizing, planning, and fully executing daily tasks.

Orr said the VR tools could be a real boost for ADHD patients, particularly during the coronavirus disease 2019 (COVID-19) pandemic.

The new tool will allow doctors to create virtual worlds where the patient must complete a task while avoiding distractions.

The new system is based on the brain’s ability to restructure itself in attempt to overcome existing challenges, referred to as the brain’s plasticity principle.